Uremic Pruritus (Chronic Kidney Disease Itching) Support Protocol
Primary Stack
Core supplements with strongest evidenceGamma-linolenic acid (GLA) may help with skin barrier function and inflammation
Supporting Studies (1)
Anti-inflammatory; may reduce systemic inflammation contributing to pruritus
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsOften deficient in CKD; may support skin health; use active form (calcitriol) if prescribed
Supporting Studies (1)
May bind uremic toxins in the gut; some studies show reduced pruritus
Supporting Studies (1)
Moisturizing and antioxidant; may help with dry skin component of uremic pruritus
Supporting Studies (1)
Often low in dialysis patients; supports skin health
Supporting Studies (1)
May reduce uremic toxin production in gut; emerging research area
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Uremic pruritus (itching) is a common and distressing symptom in chronic kidney disease (CKD), especially in patients on dialysis. It affects 40-70% of dialysis patients and can significantly impact quality of life and sleep. The exact cause is not fully understood but involves uremic toxin accumulation, inflammation, and changes in the skin.
CONTRIBUTING FACTORS:
CRITICAL: Uremic pruritus management should be coordinated with your nephrologist. Effective dialysis is the foundation of treatment.
MEDICAL TREATMENTS:
SKIN CARE:
* Evening Primrose Oil contains GLA which may support skin barrier function.
* Omega-3s may help reduce systemic inflammation.
* Topical emollients (including vitamin E) address the dry skin component.
IMPORTANT: Many supplements are processed by the kidneys. Always consult your nephrologist before starting any supplements when you have CKD.
Expected timeline: Pruritus management is ongoing. Some relief may be seen in weeks, but complete resolution is often difficult.
Clinical Perspective
Uremic Pruritus: Affects 40-70% of dialysis patients; 25-40% of CKD stage 4-5. Pathophysiology multifactorial: uremic toxins, immune dysregulation (elevated IL-6, CRP), altered opioid signaling (mu/kappa imbalance), secondary hyperparathyroidism, xerosis, peripheral neuropathy. Assessment: visual analog scale, sleep quality, quality of life measures. Differential: other causes of pruritus (liver disease, thyroid, dermatologic conditions).
CRITICAL: Optimize dialysis first - adequate Kt/V, high-flux membranes, reduce pruritogenic toxins. Medical treatment: gabapentin (adjust for CKD) most evidence; pregabalin alternative; UVB phototherapy effective; nalfurafene (kappa agonist) where available; difelikefalin approved in US. Supplements have LIMITED evidence; must consider renal clearance and accumulation. Coordinate with nephrology.
* Evening Primrose Oil (C-grade): GLA for skin. Clinical trial: (PMID: 15096533). 1-3g daily. Limited evidence.
* Omega-3 Fatty Acids (C-grade): Anti-inflammatory. Systematic review CKD: (PMID: 27840029). 2-4g EPA+DHA daily per nephrology.
* Vitamin D (C-grade): Often low; skin health. Systematic review: (PMID: 28750270). Individualized dosing. May need active form.
* Activated Charcoal (C-grade): Uremic toxin binding. Review: (PMID: 19192328). 6g daily separated from meds.
* Vitamin E (Topical) (C-grade): Moisturizing. Review: (PMID: 27918887). Apply BID.
* Zinc (C-grade): Skin health. Review: (PMID: 26845419). 15-25mg daily. Monitor levels.
* Probiotics (C-grade): Uremic toxin reduction. Systematic review: (PMID: 29882905). Multi-strain daily.
Assessment targets: Pruritus severity scale, sleep quality, skin examination, PTH, phosphorus, calcium, dialysis adequacy.
Protocol notes: Dialysis optimization: high-flux or online hemodiafiltration may reduce pruritus; adequate Kt/V; avoid underdialysis. Gabapentin: 100-300mg after dialysis (renally cleared); most evidence-based. Phototherapy: UVB 2-3x/week effective; may not be accessible. Emollients: essential - urea-based creams, ceramides; apply after dialysis and bathing. Phosphate: elevated phosphorus and PTH associated with pruritus; dietary control, binders. Sertraline: some evidence for benefit. Nalfurafene: kappa-opioid agonist; approved Japan; studied in US (difelikefalin). Antihistamines: limited efficacy; sedating types may help sleep. Menthol/camphor: topical relief. Iron overload: can worsen pruritus; consider if high ferritin. Sleep: pruritus worse at night; affects dialysis patients especially. Supplements in CKD: accumulation risk; drug interactions with phosphate binders; consult nephrology before any supplement. Transplantation: often resolves pruritus.